Angels4LifeSciences (A4LS) was established in 2012 to help overcome the perceived challenges of investing in early-stage life sciences companies.

“The importance of the life sciences sector to the UK economy has been reinforced by the government’s support for this sector, including its Strategy for UK Life Sciences and the Biomedical Catalyst. This support has helped create an environment where angel investors can make a positive return on life sciences investments”
Simon Kerry, A4LS network manager

Angels4LifeSciences (A4LS) was established in 2012 to help overcome the perceived challenges of investing in early-stage life sciences companies.

The objective of A4LS was to provide a means of communication between private investors and companies seeking investment capital in the small, high growth potential business sector.

A4LS now fully supports MedCity; further details can be found at MedCity